
Volume 7, issue 4, September 2020
20 articles in this issue
-
-
Accelerating Preclinical Alzheimer’s Clinical Trials through a Trial-Ready Cohort with Diverse Representation
Authors
- A. K. W. Lee
- S. Correia
- Stephen P. Salloway
- Content type: Editorial
- Published: 11 August 2020
- Pages: 204 - 205
-
The Trial-Ready Cohort for Preclinical/Prodromal Alzheimer’s Disease (TRC-PAD) — A Fundamental Ally in AD Prevention Research
Authors
- A. P. Porsteinsson
- E. D. Clark
- Content type: Editorial
- Published: 11 August 2020
- Pages: 206 - 207
-
The Trial-Ready Cohort for Preclinical/Prodromal Alzheimer’s Disease (TRC-PAD) Project: An Overview
Authors (first, second and last of 11)
- P. S. Aisen
- R. A. Sperling
- R. Raman
- Content type: Special Article
- Open Access
- Published: 11 August 2020
- Pages: 208 - 212
-
Predicting Amyloid Burden to Accelerate Recruitment of Secondary Prevention Clinical Trials
Authors (first, second and last of 9)
- O. Langford
- R. Raman
- TRC-PAD Investigators
- Content type: Special Article
- Open Access
- Published: 11 August 2020
- Pages: 213 - 218
-
Recruitment into the Alzheimer Prevention Trials (APT) Webstudy for a Trial-Ready Cohort for Preclinical and Prodromal Alzheimer’s Disease (TRC-PAD)
Authors (first, second and last of 11)
- S. Walter
- T. B. Clanton
- TRC-PAD Investigators
- Content type: Special Article
- Open Access
- Published: 11 August 2020
- Pages: 219 - 225
-
TRC-PAD: Accelerating Recruitment of AD Clinical Trials through Innovative Information Technology
Authors (first, second and last of 10)
- G. A. Jimenez-Maggiora
- S. Bruschi
- TRC-PAD Investigators
- Content type: Special Article
- Open Access
- Published: 16 August 2020
- Pages: 226 - 233
-
The Trial-Ready Cohort for Preclinical and Prodromal Alzheimer’s Disease (TRC-PAD): Experience from the First 3 Years
Authors (first, second and last of 11)
- S. Walter
- O. G. Langford
- TRC-PAD Investigators
- Content type: Special Article
- Open Access
- Published: 13 August 2020
- Pages: 234 - 241
-
The Alzheimer’s Prevention Registry: A Large Internet-Based Participant Recruitment Registry to Accelerate Referrals to Alzheimer’s-Focused Studies
Authors (first, second and last of 6)
- Jessica B. Langbaum
- N. High
- P. N. Tariot
- Content type: Original Research
- Open Access
- Published: 25 May 2020
- Pages: 242 - 250
-
Effectiveness of the Open Screening Programs in Recruiting Subjects to Prodromal and Mild Alzheimer’s Disease Clinical Trials
Authors (first, second and last of 4)
- Daniel Wójcik
- K. Szczechowiak
- M. Pikala
- Content type: Original Research
- Published: 02 March 2020
- Pages: 251 - 255
-
PTI-125 Reduces Biomarkers of Alzheimer’s Disease in Patients
Authors (first, second and last of 10)
- H.-Y. Wang
- Z. Pei
- Lindsay H. Burns
- Content type: Original Research
- Published: 07 February 2020
- Pages: 256 - 264
-
The Interrelationship between Insulin-Like Growth Factor 1, Apolipoprotein E ε4, Lifestyle Factors, and the Aging Body and Brain
Authors (first, second and last of 5)
- Sara A. Galle
- I.K. Geraedts
- M.L. Drent
- Content type: Reviews
- Open Access
- Published: 02 March 2020
- Pages: 265 - 273
-
A Framework for Developing Pharmacotherapy for Agitation in Alzheimer’s disease: Recommendations of the ISCTM Working Group
Authors (first, second and last of 15)
- Cedric O’Gorman
- R. Khoury
- ISCTM: International Society for CNS Clinical Trials and Methodology
- Content type: Reviews
- Open Access
- Published: 26 June 2020
- Pages: 274 - 282
-
Self-Administered Cognitive Testing by Older Adults At-Risk for Cognitive Decline
Authors (first, second and last of 8)
- Elena Tsoy
- K. L. Possin
- C. S. Ritchie
- Content type: Brief Reports
- Published: 24 April 2020
- Pages: 283 - 287
-
The Role of Clinical Trials in Preclinical Alzheimer’s Disease Drug Development Programs
Authors
- Jeffrey Cummings
- Content type: Viewpoint
- Open Access
- Published: 06 May 2020
- Pages: 288 - 290
-
A Missed Opportunity for Dementia Prevention? Current Challenges for Early Detection and Modern-Day Solutions
Authors
- Richard S. Isaacson
- N. Saif
- Content type: Viewpoint
- Open Access
- Published: 17 April 2020
- Pages: 291 - 293
-
The Sars-Cov-2 Pandemic and the Brave New Digital World of Environmental Enrichment to Prevent Brain Aging and Cognitive Decline
Authors
- Harald Hampel
- Andrea Vergallo
- Content type: Viewpoint
- Published: 13 July 2020
- Pages: 294 - 298
-
Letter to the editor referring to P.S. Aisen and R. Raman, Futility Analyses in Alzheimer’s Disease (AD) Clinical Trials: A Risky Business. The Journal of Prevention of Alzheimer’s Disease, 2020
Authors
- Daniel Umbricht
- Content type: Letter to the Editor
- Published: 01 June 2020
- Pages: 299 - 300
-
Authors response to D. Umbricht letter to the editor referring Futility Analyses in Alzheimer’s Disease (AD) Clinical Trials: A Risky Business. The Journal of Prevention of Alzheimer’s Disease, 2020
Authors
- P. S. Aisen
- R. Raman
- Content type: Response to the Letter to the Editor
- Published: 01 June 2020
- Pages: 300 - 300
-
Toulouse Alzheimer’s Clinical Research Center Recovery after the COVID-19 Crisis: Telemedicine an Innovative Solution for Clinical Research during the Coronavirus Pandemic
Authors (first, second and last of 5)
- C. Takeda
- S. Guyonnet
- B. Vellas
- Content type: Letter to the Editor
- Published: 25 May 2020
- Pages: 301 - 304
For authors
Submit manuscriptWorking on a manuscript?
Avoid the most common mistakes and prepare your manuscript for journal editors.
Learn more